Publications

UICentre Publications List

ARTICLE CITATION (NLM)	JOURNAL INFO	DATE	LINKS
Li Y, Ma J, Bott R, McMullan LK, Lo MK, Chatterjee P, Flint M, Spengler JR, Kunz KA, Argade MD, Ratia K, Rong R, Carlier PR, Rong L. Dihydroorotate Dehydrogenase Inhibitors are Potent Antiviral Agents against Henipaviruses and Arenaviruses. Antiviral Research. 2026, 254:106507. doi: https://doi.org/10.1016/j.antiviral.2026.106507. Epub 2026 Aug 11.	Antiviral Res. 2026 Aug 11;254:106507	2026-08-11	doi: 10.1016/j.antiviral.2026.106507 PMID: 42580486 PMCID:
Velma GR, Kumar S, Srivastava P, Misra S, Nair RS, Musku SR, Ackerman-Berrier M, Alves EMT, Singh SK, Vyas H, Rana B, Xiong R, Bloem L, Rana A, Thatcher GRJ. Mixed Lineage Kinase Suppression in Triple-Negative Breast Cancer: Identification of a Dual Inhibitor Targeting MLK3 and NAMPT. J Med Chem. 2026 Jun 18;69(12):14191-14212. doi: 10.1021/acs.jmedchem.5c03558. Epub 2026 Jun 10. PMID: 42269602.	J Med Chem. 2026 Jun 18;69(12):14191-14212	2026-06-10	doi: 10.1021/acs.jmedchem.5c03558 PMID: 42269602 PMCID:
Gaisina IN, Argade MD, Bott R, Bradley SP, Tomorowicz Ł, Alvarez M, Galván Achi JM, Cross RW, Borisevich V, O'Toole R, Amaya M, Zielinski CA, Gaisin AM, Nikolic D, Carlier PR, Anantpadma M, Moore TW, Broder CC, Geisbert TW, Peet NP, Rong L. Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of Henipaviruses. J Med Chem. 2026 Jan 22;69(2):1264-1285. doi: 10.1021/acs.jmedchem.5c02646. Epub 2026 Jan 5. PMID: 41492812.	J Med Chem. 2026 Jan 22;69(2):1264-1285	2026-01-22	doi: 10.1021/acs.jmedchem.5c02646 PMID: 41492812 PMCID:
Gannarapu MR, Indukuri D, Holberg C, Ratia K, Ramos OL, Cardoza S, Velma GR, Musku SR, Qi Z, Slilaty S, Li Z, Rong L, Thatcher GRJ, Xiong R. Discovery of the SARS-CoV-2 Papain-Like Protease Inhibitor MR1-114: From Structure-Based Design to In Vivo Antiviral Efficacy. J Med Chem. 2026 Apr 9;69(7):8433-8450. doi: 10.1021/acs.jmedchem.5c03846. Epub 2026 Mar 26. PMID: 41886743; PMCID: PMC13071871.	J Med Chem. 2026 Apr 9;69(7):8433-8450	2026-03-26	doi: 10.1021/acs.jmedchem.5c03846 PMID: 41886743 PMCID: PMC13071871
Valencia-Olvera AC, Marottoli FM, Ratia K, Thatcher GR, Tai LM. Proof-of-concept study: APOE4 brain endothelial cells as a phenotypic compound screen. Alzheimers Res Ther. 2026 Feb 2;18(1):54. doi: 10.1186/s13195-026-01960-6. PMID: 41622232; PMCID: PMC12964606.	Alzheimers Res Ther. 2026 Feb 2;18(1):54	2026-02-02	doi: 10.1186/s13195-026-01960-6 PMID: 41622232 PMCID: PMC12964606
Khin M, Saldana AC, Rangel-Grimaldo M, Raja HA, Abegg D, Ekiert J, Liu C, Misra S, Ratia K, Adibekian A, Gao Y, Kulp SK, Coss CC, Oberlies NH, Burdette JE. Natural Product Target Identification of Wheldone, a Fungal Metabolite, as a KIF11 Inhibitor in Ovarian Cancer Using the DiffPOP (Differential Protein Precipitation) Method. Mol Cell Proteomics. 2026 May;25(5):101558. doi: 10.1016/j.mcpro.2026.101558. Epub 2026 Mar 23. PMID: 41881190; PMCID: PMC13122309.	Mol Cell Proteomics. 2026 May;25(5):101558	2026-03-23	doi: 10.1016/j.mcpro.2026.101558 PMID: 41881190 PMCID: PMC13122309
Wang Z, Zhang P, Ratia KM, Daher A, Zhao Z, Carlier PR, Jiang Y, Rong L. Development of a comparative high-throughput screening platform for identifying glioblastoma subtype specific inhibitors. Cell Insight. 2025 Sep 29;4(6):100284. doi: 10.1016/j.cellin.2025.100284. PMID: 41321709; PMCID: PMC12657333.	Cell Insight. 2025 Sep 29;4(6):100284	2025-09-29	doi: 10.1016/j.cellin.2025.100284 PMID: 41321709 PMCID: PMC12657333
Bradley SP, Galván Achi JM, Cooper L, Argade MD, Cheng H, Bott R, Zielinski CA, Gaisin AM, Jesikiewicz LT, Villegas JA, et al. Discovery and Characterization of 7,8-Dihydropyrido[4,3-d]pyrimidines as SARS-CoV-2 Entry Inhibitors. Drugs and Drug Candidates. 2025; 4(4):47. https://doi.org/10.3390/ddc4040047	Drugs and Drug Candidates. 2025; 4(4):47	2025-10-29	doi: 10.3390/ddc4040047 PMID: PMCID:
Xu Y, Anirudhan V, Gaisina IN, Du H, Alqarni S, Moore TW, Caffrey M, Manicassamy B, Zhou T, Rong L, Xu K. Mechanistic insights into the small-molecule inhibition of influenza A virus entry. Proc Natl Acad Sci U S A. 2025 Aug 19;122(33):e2503899122. doi: 10.1073/pnas.2503899122. Epub 2025 Aug 13. PMID: 40802690; PMCID: PMC12377760.	Proc Natl Acad Sci U S A. 2025 Aug 19;122(33):e2503899122	2025-08-19	doi: 10.1073/pnas.2503899122 PMID: 40802690 PMCID: PMC12377760
Durante D, Murugesh V, Kalanquin T, Gaisina IN, Rong L, Moore TW. Small molecule drug discovery for Ebola virus disease. RSC Med Chem. 2025 Aug 6;16(10):4571-4598. doi: 10.1039/d5md00533g. PMID: 40852580; PMCID: PMC12365685.	RSC Med Chem. 2025 Aug 6;16(10):4571-4598	2025-08-06	doi: 10.1039/d5md00533g PMID: 40852580 PMCID: PMC12365685
Anirudhan V, Gaisina I, Shimon A, Lee H, Alqarni S, Manicassamy B, Moore TW, Xu K, Caffrey M, Rong L. Effect of pH on small-molecule inhibitor binding to influenza virus hemagglutinin. J Biol Chem. 2026 Mar;302(3):111150. doi: 10.1016/j.jbc.2026.111150. Epub 2026 Jan 10. PMID: 41525845; PMCID: PMC12887400.	J Biol Chem. 2026 Mar;302(3):111150	2026-01-10	doi: 10.1016/j.jbc.2026.111150 PMID: 41525845 PMCID: PMC12887400
Hushpulian DM, Kaidery NA, Soni P, Poloznikov AA, Zakhariants AA, Razumovskaya AV, Silkina MO, Tishkov VI, Kazakov EH, Brown AM, Gaisina IN, Ahn YH, Kazakov SV, Krucher N, Sharma SM, Paul BD, Gazaryan IG, Nikulin SV, Thomas B. Functional analysis of bipartite NRF2 activators that overcome feedback regulation for age-related chronic diseases. Redox Biol. 2025 Oct;86:103794. doi: 10.1016/j.redox.2025.103794. Epub 2025 Jul 30. PMID: 40779837; PMCID: PMC12356038.	Redox Biol. 2025 Oct;86:103794	2025-07-30	doi: 10.1016/j.redox.2025.103794 PMID: 40779837 PMCID: PMC12356038
Li Y, Shen Z, Ratia K, Zhao J, Huang F, Dubrovyskyii O, Indukuri D, Fu J, Lozano Ramos O, Thatcher GRJ, Xiong R. Structure-Guided Design and Synthesis of Pyridinone-Based Selective Bromodomain and Extra-Terminal Domain (BET)-First Bromodomain (BD1) Inhibitors. J Med Chem. 2024 Feb 22;67(4):2712-2731. doi: 10.1021/acs.jmedchem.3c01837. Epub 2024 Jan 31. PMID: 38295759.	J Med Chem. 2024 Feb 22;67(4):2712-2731	2024-02-22	doi: 10.1021/acs.jmedchem.3c01837 PMID: 38295759 PMCID:
Shen Z, Ratia K, Krider I, Ackerman-Berrier M, Penton C, Musku SR, Gordon-Blake JM, Laham MS, Christie N, Ma N, Fu J, Xiong R, Courey JM, Velma GR, Thatcher GRJ. Synthesis, Optimization, and Structure-Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs). J Med Chem. 2023 Dec 28;66(24):16704-16727. doi: 10.1021/acs.jmedchem.3c01406. Epub 2023 Dec 14. PMID: 38096366; PMCID: PMC10758216.	J Med Chem. 2023 Dec 28;66(24):16704-16727	2023-12-28	doi: 10.1021/acs.jmedchem.3c01406 PMID: 38096366 PMCID: PMC10758216
Petukhova VZ, Aboagye SY, Ardini M, Lullo RP, Fata F, Byrne ME, Gabriele F, Martin LM, Harding LNM, Gone V, Dangi B, Lantvit DD, Nikolic D, Ippoliti R, Effantin G, Ling WL, Johnson JJ, Thatcher GRJ, Angelucci F, Williams DL, Petukhov PA. Non-covalent inhibitors of thioredoxin glutathione reductase with schistosomicidal activity in vivo. Nat Commun. 2023 Jun 22;14(1):3737. doi: 10.1038/s41467-023-39444-y. PMID: 37349300; PMCID: PMC10287695.	Nat Commun. 2023 Jun 22;14(1):3737	2023-06-22	doi: 10.1038/s41467-023-39444-y PMID: 37349300 PMCID: PMC10287695
Nair RS, Kumar S, Das S, Singh SK, Srivastava P, Sondarva G, Rao A, Sinha SC, Xiong R, Bloem L, Hoskins K, Thatcher GRJ, Rana B, Rana A. TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer. Oncogene. 2023 Mar;42(14):1132-1143. doi: 10.1038/s41388-023-02633-6. Epub 2023 Feb 22. PMID: 36813855.	Oncogene. 2023 Mar;42(14):1132-1143	2023-03-01	doi: 10.1038/s41388-023-02633-6 PMID: 36813855 PMCID:
Ratia KM, Shen Z, Gordon-Blake J, Lee H, Laham MS, Krider IS, Christie N, Ackerman-Berrier M, Penton C, Knowles NG, Musku SR, Fu J, Velma GR, Xiong R, Thatcher GRJ. Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD. Biochemistry. 2023 Feb 21;62(4):923-933. doi: 10.1021/acs.biochem.2c00655. Epub 2023 Feb 6. PMID: 36746631; PMCID: PMC10935581.	Biochemistry. 2023 Feb 21;62(4):923-933	2023-02-21	doi: 10.1021/acs.biochem.2c00655 PMID: 36746631 PMCID:
Alqarni S, Cooper L, Galvan Achi J, Bott R, Sali VK, Brown A, Santarsiero BD, Krunic A, Manicassamy B, Peet NP, Zhang P, Thatcher GRJ, Gaisina IN, Rong L, Moore TW. Synthesis, Optimization, and Structure-Activity Relationships of Imidazo[1,2-a]pyrimidines as Inhibitors of Group 2 Influenza A Viruses. J Med Chem. 2022 Oct 27;65(20):14104-14120. doi: 10.1021/acs.jmedchem.2c01329. Epub 2022 Oct 19. PMID: 36260129.	J Med Chem. 2022 Oct 27;65(20):14104-14120	2022-10-27	doi: 10.1021/acs.jmedchem.2c01329 PMID: 36260129 PMCID:
Shen Z, Ratia K, Cooper L, Kong D, Lee H, Kwon Y, Li Y, Alqarni S, Huang F, Dubrovskyi O, Rong L, Thatcher GRJ, Xiong R. Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity. J Med Chem. 2022 Feb 24;65(4):2940-2955. doi: 10.1021/acs.jmedchem.1c01307. Epub 2021 Oct 19. PMID: 34665619; PMCID: PMC8547495.	J Med Chem. 2022 Feb 24;65(4):2940-2955	2022-02-24	doi: 10.1021/acs.jmedchem.1c01307 PMID: 34665619 PMCID: PMC8547495
Shen Z, Ratia K, Cooper L, Kong D, Lee H, Kwon Y, Li Y, Alqarni S, Huang F, Dubrovskyi O, Rong L, Thatcher GRJ, Xiong R. Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity. J Med Chem. 2022 Feb 24;65(4):2940-2955. doi: 10.1021/acs.jmedchem.1c01307. Epub 2021 Oct 19. PMID: 34665619; PMCID: PMC8547495.	J Med Chem. 2022 Feb 24;65(4):2940-2955	2022-02-24	doi: 10.1021/acs.jmedchem.1c01307 PMID: 34665619 PMCID: PMC8547495
Principe DR, Xiong R, Li Y, Pham TND, Kamath SD, Dubrovskyi O, Ratia K, Huang F, Zhao J, Shen Z, Thummuri D, Daohong Z, Underwood PW, Trevino J, Munshi HG, Thatcher GRJ, Rana A. XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer. Proc Natl Acad Sci U S A. 2022 Jan 25;119(4):e2116764119. doi: 10.1073/pnas.2116764119. PMID: 35064087; PMCID: PMC8795568.	Proc Natl Acad Sci U S A. 2022 Jan 25;119(4):e2116764119	2022-01-25	doi: 10.1073/pnas.2116764119 PMID: 35064087 PMCID: PMC8795568
Poloznikov AA, Nikulin SV, Hushpulian DM, Khristichenko AY, Osipyants AI, Asachenko AF, Shurupova OV, Savin SS, Lee SH, Gaisina IN, Thatcher GRJ, Narciso A, Chang EP, Kazakov SV, Krucher N, Tishkov VI, Thomas B, Gazaryan IG. Structure-Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors. Antioxidants (Basel). 2022 Jan 24;11(2):220. doi: 10.3390/antiox11020220. PMID: 35204103; PMCID: PMC8868400.	Antioxidants (Basel). 2022 Jan 24;11(2):220	2022-01-24	doi: 10.3390/antiox11020220 PMID: 35204103 PMCID: PMC8868400
Dubrovskyi O, Hasten E, Dudek SM, Flavin MT, Chan LL. Development of an Image-Based HCS-Compatible Method for Endothelial Barrier Function Assessment. SLAS Discov. 2021 Oct;26(9):1079-1090. doi: 10.1177/24725552211030900. Epub 2021 Jul 16. PMID: 34269109.	SLAS Discov. 2021 Oct;26(9):1079-1090	2021-10-01	doi: 10.1177/24725552211030900 PMID: 34269109 PMCID:
Amaya M, Cheng H, Borisevich V, Navaratnarajah CK, Cattaneo R, Cooper L, Moore TW, Gaisina IN, Geisbert TW, Rong L, Broder CC. A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery. Antiviral Res. 2021 Sep;193:105084. doi: 10.1016/j.antiviral.2021.105084. Epub 2021 May 30. PMID: 34077807; PMCID: PMC8631057.	Antiviral Res. 2021 Sep;193:105084	2021-09-01	doi: 10.1016/j.antiviral.2021.105084 PMID: 34077807 PMCID: PMC8631057
Choi JV, Tchernookova BK, Kumar W, Kiedrowski L, Goeke C, Guizzetti M, Larson J, Kreitzer MA, Malchow RP. Extracellular ATP-Induced Alterations in Extracellular H+ Fluxes From Cultured Cortical and Hippocampal Astrocytes. Front Cell Neurosci. 2021 Apr 30;15:640217. doi: 10.3389/fncel.2021.640217. PMID: 33994945; PMCID: PMC8120152.	Front Cell Neurosci. 2021 Apr 30;15:640217	2021-04-30	doi: 10.3389/fncel.2021.640217 PMID: 33994945 PMCID: PMC8120152
Lewandowski CT, Khan MW, BenAissa M, Dubrovskyi O, Ackerman-Berrier M, LaDu MJ, Layden BT, Thatcher GRJ. Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development. EBioMedicine. 2021 Apr;66:103287. doi: 10.1016/j.ebiom.2021.103287. Epub 2021 Mar 19. PMID: 33752129; PMCID: PMC8010624.	EBioMedicine. 2021 Apr;66:103287	2021-04-01	doi: 10.1016/j.ebiom.2021.103287 PMID: 33752129 PMCID: PMC8010624
Shen Z, Ratia K, Cooper L, Kong D, Lee H, Kwon Y, Li Y, Alqarni S, Huang F, Dubrovskyi O, Rong L, Thatcher GR, Xiong R. Potent, Novel SARS-CoV-2 PLpro Inhibitors Block Viral Replication in Monkey and Human Cell Cultures. bioRxiv [Preprint]. 2021 Feb 15:2021.02.13.431008. doi: 10.1101/2021.02.13.431008. Update in: J Med Chem. 2021 Oct 19;: PMID: 33594371; PMCID: PMC7885923.	bioRxiv [Preprint]. 2021 Feb 15:2021	2021-02-15	doi: 10.1101/2021.02.13.431008 PMID: 33594371 PMCID: PMC7885923
Scheinman SB, Zaldua S, Dada A, Krochmaliuk K, Dye K, Marottoli FM, Thatcher GRJ, Tai LM. Systemic Candesartan Treatment Modulates Behavior, Synaptic Protein Levels, and Neuroinflammation in Female Mice That Express Human APOE4. Front Neurosci. 2021 Feb 10;15:628403. doi: 10.3389/fnins.2021.628403. PMID: 33642985; PMCID: PMC7902885.	Front Neurosci. 2021 Feb 10;15:628403	2021-02-10	doi: 10.3389/fnins.2021.628403 PMID: 33642985 PMCID: PMC7902885
Schafer A, Xiong R, Cooper L, Nowar R, Lee H, Li Y, Ramirez BE, Peet NP, Caffrey M, Thatcher GRJ, Saphire EO, Cheng H, Rong L. Evidence for distinct mechanisms of small molecule inhibitors of filovirus entry. PLoS Pathog. 2021 Feb 4;17(2):e1009312. doi: 10.1371/journal.ppat.1009312. PMID: 33539432; PMCID: PMC7888603.	PLoS Pathog. 2021 Feb 4;17(2):e1009312	2021-02-04	doi: 10.1371/journal.ppat.1009312 PMID: 33539432 PMCID: PMC7888603
Knopp RC, Jastaniah A, Dubrovskyi O, Gaisina I, Tai L, Thatcher GRJ. Extending the Calpain-Cathepsin Hypothesis to the Neurovasculature: Protection of Brain Endothelial Cells and Mice from Neurotrauma. ACS Pharmacol Transl Sci. 2021 Feb 2;4(1):372-385. doi: 10.1021/acsptsci.0c00217. PMID: 33615187; PMCID: PMC7887848.	ACS Pharmacol Transl Sci. 2021 Feb 2;4(1):372-385	2021-02-02	doi: 10.1021/acsptsci.0c00217 PMID: 33615187 PMCID: PMC7887848
Du R, Cheng H, Cui Q, Peet NP, Gaisina IN, Rong L. Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins. Antiviral Res. 2021 Feb;186:105013. doi: 10.1016/j.antiviral.2021.105013. Epub 2021 Jan 8. PMID: 33428962; PMCID: PMC8813174.	Antiviral Res. 2021 Feb;186:105013	2021-02-01	doi: 10.1016/j.antiviral.2021.105013 PMID: 33428962 PMCID: PMC8813174
Ben Aissa M, Lewandowski CT, Ratia KM, Lee SH, Layden BT, LaDu MJ, Thatcher GRJ. Discovery of Nonlipogenic ABCA1 Inducing Compounds with Potential in Alzheimer's Disease and Type 2 Diabetes. ACS Pharmacol Transl Sci. 2021 Jan 5;4(1):143-154. doi: 10.1021/acsptsci.0c00149. PMID: 33615168; PMCID: PMC7887740.	ACS Pharmacol Transl Sci. 2021 Jan 5;4(1):143-154	2021-01-05	doi: 10.1021/acsptsci.0c00149 PMID: 33615168 PMCID: PMC7887740
Jastaniah A, Gaisina IN, Knopp RC, Thatcher GRJ. Synthesis of α-Ketoamide-Based Stereoselective Calpain-1 Inhibitors as Neuroprotective Agents. ChemMedChem. 2020 Dec 3;15(23):2280-2285. doi: 10.1002/cmdc.202000385. Epub 2020 Sep 18. PMID: 32840034; PMCID: PMC8583780.	ChemMedChem. 2020 Dec 3;15(23):2280-2285	2020-12-03	doi: 10.1002/cmdc.202000385 PMID: 32840034 PMCID: PMC8583780
Cutler Lewandowski, Md. Wasim Khan, Manel Ben Aissa, Brian Layden and Gregory Thatcher. Discovery and Preclinical Optimization of Selective ABCA1 Inducers as Multifunctional Therapeutic Candidates. Circulation. 2020 Nov 12;	Circulation. 2020 Nov 12	2020-11-12	doi: 10.1161/circ.142.suppl_3.15297 PMID: PMCID:
Cooper L, Schafer A, Li Y, Cheng H, Medegan Fagla B, Shen Z, Nowar R, Dye K, Anantpadma M, Davey RA, Thatcher GRJ, Rong L, Xiong R. Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors. J Med Chem. 2020 Oct 8;63(19):11085-11099. doi: 10.1021/acs.jmedchem.0c01001. Epub 2020 Sep 22. PMID: 32886512; PMCID: PMC7904233.	J Med Chem. 2020 Oct 8;63(19):11085-11099	2020-10-08	doi: 10.1021/acs.jmedchem.0c01001 PMID: 32886512 PMCID: PMC7904233
Abderrahman B, Maximov PY, Curpan RF, Hanspal JS, Fan P, Xiong R, Tonetti DA, Thatcher GRJ, Jordan VC. Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer. Mol Pharmacol. 2020 Oct;98(4):364-381. doi: 10.1124/molpharm.120.000054. Epub 2020 Aug 12. Erratum in: Mol Pharmacol. 2020 Oct;98(4):528. PMID: 32788222; PMCID: PMC7491312.	Mol Pharmacol. 2020 Oct;98(4):364-381	2020-10-01	doi: 10.1124/molpharm.120.000054 PMID: 32788222 PMCID: PMC7491312
Li Y, Zhao J, Gutgesell LM, Shen Z, Ratia K, Dye K, Dubrovskyi O, Zhao H, Huang F, Tonetti DA, Thatcher GRJ, Xiong R. Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib. J Med Chem. 2020 Jul 9;63(13):7186-7210. doi: 10.1021/acs.jmedchem.0c00456. Epub 2020 Jun 15. PMID: 32453591; PMCID: PMC8258866.	J Med Chem. 2020 Jul 9;63(13):7186-7210	2020-07-09	doi: 10.1021/acs.jmedchem.0c00456 PMID: 32453591 PMCID: PMC8258866
Gaisina IN, Peet NP, Wong L, Schafer AM, Cheng H, Anantpadma M, Davey RA, Thatcher GRJ, Rong L. Discovery and Structural Optimization of 4-(Aminomethyl)benzamides as Potent Entry Inhibitors of Ebola and Marburg Virus Infections. J Med Chem. 2020 Jul 9;63(13):7211-7225. doi: 10.1021/acs.jmedchem.0c00463. Epub 2020 Jun 17. PMID: 32490678; PMCID: PMC7671190.	J Med Chem. 2020 Jul 9;63(13):7211-7225	2020-07-09	doi: 10.1021/acs.jmedchem.0c00463 PMID: 32490678 PMCID: PMC7671190
Antanasijevic A, Durst MA, Cheng H, Gaisina IN, Perez JT, Manicassamy B, Rong L, Lavie A, Caffrey M. Structure of avian influenza hemagglutinin in complex with a small molecule entry inhibitor. Life Sci Alliance. 2020 Jul 1;3(8):e202000724. doi: 10.26508/lsa.202000724. PMID: 32611549; PMCID: PMC7335401.	Life Sci Alliance. 2020 Jul 1;3(8):e202000724	2020-07-01	doi: 10.26508/lsa.202000724 PMID: 32611549 PMCID: PMC7335401
Pavlinov I, Salkovski M, Aldrich LN. Beclin 1-ATG14L Protein-Protein Interaction Inhibitor Selectively Inhibits Autophagy through Disruption of VPS34 Complex I. J Am Chem Soc. 2020 May 6;142(18):8174-8182. doi: 10.1021/jacs.9b12705. Epub 2020 Apr 22. PMID: 32320221.	J Am Chem Soc. 2020 May 6;142(18):8174-8182	2020-05-06	doi: 10.1021/jacs.9b12705 PMID: 32320221 PMCID: